Publicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (63)

2024

  1. Clustering COVID-19 ARDS patients through the first days of ICU admission. An analysis of the CIBERESUCICOVID Cohort

    Critical Care, Vol. 28, Núm. 1

  2. MicroRNA-centered theranostics for pulmoprotection in critical COVID-19

    Molecular Therapy Nucleic Acids, Vol. 35, Núm. 1

  3. MicroRNA-guided drug discovery for mitigating persistent pulmonary complications in critical COVID-19 survivors: A longitudinal pilot study

    British Journal of Pharmacology

  4. Recommendations for detection, validation, and evaluation of RNA editing events in cardiovascular and neurological/neurodegenerative diseases

    Molecular Therapy Nucleic Acids, Vol. 35, Núm. 1

  5. Searching for New Biomarkers in Respiratory Medicine: Present and Future of miRNAs

    Archivos de Bronconeumologia

  6. microRNA Expression Profile in Obesity-Induced Kidney Disease Driven by High-Fat Diet in Mice

    Nutrients, Vol. 16, Núm. 5

2023

  1. A blood microRNA classifier for the prediction of ICU mortality in COVID-19 patients: a multicenter validation study

    Respiratory Research, Vol. 24, Núm. 1

  2. Cardiovascular complications of diabetes: role of non-coding RNAs in the crosstalk between immune and cardiovascular systems

    Cardiovascular Diabetology, Vol. 22, Núm. 1

  3. Circulating lipoprotein-carried miRNome analysis reveals novel VLDL-enriched microRNAs that strongly correlate with the HDL-microRNA profile

    Biomedicine and Pharmacotherapy, Vol. 162

  4. Circulating miR-133a-3p defines a low-risk subphenotype in patients with heart failure and central sleep apnea: a decision tree machine learning approach

    Journal of Translational Medicine, Vol. 21, Núm. 1

  5. Clinical Outcomes of Critical COVID-19 in HIV-Infected Adults: A Propensity Score Matched Analysis

    Archivos de Bronconeumologia, Vol. 59, Núm. 11, pp. 772-778

  6. Clinical and pulmonary function analysis in long-COVID revealed that long-term pulmonary dysfunction is associated with vascular inflammation pathways and metabolic syndrome

    Frontiers in Medicine, Vol. 10

  7. Development of circulating microRNA-based biomarkers for medical decision-making: a friendly reminder of what should NOT be done

    Critical Reviews in Clinical Laboratory Sciences, Vol. 60, Núm. 2, pp. 141-152

  8. Driving pressure and adjunctive therapies in pulmonary sequelae of COVID-19 patients under invasive ventilation

    Intensive Care Medicine

  9. Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study

    The Lancet Microbe, Vol. 4, Núm. 6, pp. e431-e441

  10. Effects of intubation timing in patients with COVID-19 throughout the four waves of the pandemic: a matched analysis

    The European respiratory journal, Vol. 61, Núm. 3

  11. Hyperglycemia in Acute Critically Ill COVID-19 Patients

    Archivos de Bronconeumologia, Vol. 59, Núm. 1, pp. 51-56

  12. Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215

  13. Long-term Outcomes in Critical COVID-19 Survivors: A 2-Year Longitudinal Cohort

    Archivos de Bronconeumologia, Vol. 59, Núm. 10, pp. 691-697

  14. Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients

    Intensive Care Medicine, Vol. 49, Núm. 8, pp. 934-945